All companies
Visit website
Koning
OperatingKoning Corp
Healthcare · Founded 2002
Minority-founded
A better way of breast imaging
Post-money valuation ⓘ
$230.8M
As of Dec 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$3,186,374
Across 2 rounds since 2021
Latest share price
$5.69
Reg CF Offering (2022) offering price
Financials
FY2019–FY2023 · from SEC filings · hover any figure for its source$2.2M
−$1.7M
2019
$2.2M
−$1.7M
2020
$358K
−$4.9M
2021
$1.4M
−$4.5M
2022
$5.6M
−$1.0M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$2,163,088
$2,163,088
$357,779
$1,418,566
$5,582,800
Cost of goods sold
$93,669
$93,669
$153,022
$628,887
$3,000,000
Gross margin
96%
96%
57%
56%
46%
Net income
-$1,746,975
-$1,746,975
-$4,869,465
-$4,505,887
-$1,005,082
Taxes paid
-$7,590
-$7,590
$65
$11,207
$4,350
Balance sheet
Cash
$402,671
$402,671
$2,535,470
$1,101,137
$686,490
Accounts receivable
$33,103
$33,103
$322,892
$866,456
$3,359,418
Total assets
$25,550,691
$25,550,691
$26,507,126
$27,499,563
$29,520,137
Short-term debt
$2,362,160
$2,362,160
$47,116
$4,889,411
$5,396,019
Long-term debt
$1,000,000
$1,000,000
$3,558,360
$1,221,400
$3,558,360
Total liabilities
$3,362,160
$3,362,160
$3,605,476
$6,110,811
$8,954,379
Other
Headcount
—
18
13
17
22
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$200.0M
Valuation cap
$230.8M
post-money
Koning Crowd SAFE 1
Reg CF Offering (2022)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $492.1K / $2.9MInvestors 388Post-money $230.8M
Raised $2.7M / $5MInvestors 2,489Valuation cap $200M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 3 of 5 annual reports (FY2021–FY2025)
2,489 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001174199Share price $5.69
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.